October 19, 2021 News by Marta Figueiredo, PhD #ECTRIMS2021 ā Spinal Cord Lesions Predictive of SPMS Conversion in CIS Editorās note: TheĀ Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13ā15. GoĀ hereĀ to see the latest stories from the conference. Lesions…
January 12, 2021 News by Diana Campelo Delgado Lemtrada May Slow MS Disease Progression, Long-term Study Suggests LemtradaĀ (alemtuzumab) may slow the progression of multiple sclerosis (MS) and lower the conversion rate of relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS), a long-term study suggests. The results showed that patients converting to SPMS ā in which a personās disability gets steadily worse ā were older,…
December 2, 2020 News by Steve Bryson, PhD Aubagio Slows Grey Matter, Whole Brain Atrophy in CIS, Study Finds Studied for the first time,Ā Aubagio (teriflunomide) slowed the loss of cortical grey matter and whole-brain volume in people with clinically isolated syndrome (CIS) during two years of therapy, a study found. The treatment was especially effective in those without brain lesions before treatment.
July 30, 2020 News by Marta Figueiredo, PhD Healthy Diet May Lower Risk of Relapse After 1st Myelin Attack, Study Suggests A “prudent” diet rich in fresh fruit, non-fried fish, whole grains, vegetables, and nuts may lower the likelihood of a relapse in people with a first demyelinating event, a major risk factor forĀ multiple sclerosis (MS), a study in Australia suggests. While the researchers did not find a strong link…
November 1, 2019 News by Iqra Mumal, MSc Study: 40% of SPMS Patients in Italy and Germany Unaware of Diagnosis A new study shows that 40% of patients in Italy and Germany who have Ā secondary progressive multiple sclerosis (SPMS) are not aware of their diagnosis, indicating a need for significant improvement in patient-physician communication.
September 26, 2019 News by Marisa Wexler, MS MRI Marker May Be Better at Predicting MS Disease Progression, Study Finds The volume of atrophied (shrunken) regions in the brain, as visible through magnetic resonance imaging (MRI) scans, can predict disease progression in people with multiple sclerosis (MS), new research reveals. The finding was published in the journalĀ Radiology in an article titled, “Atrophied Brain T2 Lesion Volume…
July 24, 2019 News by Alejandra Viviescas, PhD Conversion to MS Among Taiwanese with CIS Low and Disease Course Mild, Study Finds The percentage of Taiwanese who develop multiple sclerosis (MS) after an episode of clinically isolated syndrome (CIS) is lower than that reported for other ethnicities, and those who do progress are likely to have a milder disease course, a study found, supporting how factors like geography and genetics…
March 1, 2019 News by Jonathan Grinstein #ACTRIMS2019 – RRMS Conversion to SPMS Is Preceded by Spinal Cord Atrophy The rate of spinal cord tissue loss is a strong indicator of conversion fromĀ relapsing-remitting multiple sclerosis (RRMS)Ā to secondary progressive MS (SPMS), according to a finding presented at theĀ fourth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2019. The forum…
October 10, 2018 News by Ana Pena PhD #ECTRIMS2018 – DMTs Slow Down Disability Progression in SPMS Patients with Ongoing Relapses, Analysis Shows Treatment with disease-modifying therapies (DMTs) may benefit patients with secondary progressive multiple sclerosis (SPMS) who are actively experiencing relapses, as they can slow the disability’s worsening, a new analysis of an MS patient registry shows. Patients…
May 14, 2018 News by Jose Marques Lopes, PhD B-Cell Changes May Predict Conversion from Clinically Isolated Syndrome to MS, Study Suggests B-cell alterations in peripheral blood may predict the conversion of clinically isolated syndrome (CIS) to multiple sclerosis (MS), a recent study suggests. Conducted in Turkey, the study, āPeripheral blood memory B cell frequency predicts conversion from clinically isolated syndrome to multiple sclerosis,ā was published in…
December 1, 2017 News by Patricia Inacio, PhD Researchers Discover Molecules that Accelerate Reprogramming of Cells Researchers at the MRC Centre for Regenerative Medicine, University of Edinburgh, have discovered a mechanism that accelerates reprogramming of cells into any other cell type.Ā The finding may help boost drug discovery and cellular therapies for several diseases, including multiple sclerosis (MS). The study reporting the findings, ā…